The chemical class known as LOC100040214 Inhibitors encompasses a range of compounds specifically designed to interact with the LOC100040214 gene product. This interaction is characterized by a targeted approach, aimed at inhibiting the biological functions attributed to this gene. The LOC100040214 gene, identified through advanced genomic studies, plays a critical role in various cellular mechanisms, although the precise nature of its function can vary significantly depending on the cellular context and environmental factors. Inhibitors targeting this gene are engineered to bind selectively and effectively to the proteins or enzymes resulting from the gene's expression. By binding to these gene products, these inhibitors modulate their activity, which in turn impacts the biochemical pathways involving the gene product.
Creating LOC100040214 Inhibitors is a complex process that melds aspects of molecular biology, biochemistry, and organic chemistry. The development process begins with an in-depth understanding of the target gene product's structure and biological role. This understanding is often achieved through sophisticated techniques like X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling. Such detailed insights enable the rational design of inhibitors that are not only effective in their interaction but also exhibit high selectivity for their target. These inhibitors are generally small molecules, crafted to efficiently penetrate cellular membranes and reach their target. They are meticulously designed to ensure a robust and stable interaction with the target molecule. This interaction typically involves a combination of hydrogen bonds, hydrophobic interactions, and van der Waals forces. The effectiveness of these inhibitors is assessed through various in vitro biochemical assays. These assays are instrumental in evaluating the inhibitor's capacity to reduce the activity of the gene product, assessing factors such as potency, selectivity, and overall interaction dynamics. These studies are essential for establishing a foundational understanding of the inhibitor's behavior and interaction mechanisms in controlled environments.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA polymerase, which can lead to a decrease in mRNA synthesis for various genes. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
A potent inhibitor of RNA polymerase II, affecting mRNA production during transcription. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Binds to bacterial RNA polymerase, but in eukaryotes, can affect mitochondrial RNA polymerase. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits transcription elongation by targeting RNA polymerase II. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
A diterpene triepoxide that can inhibit the transcription of various genes by affecting RNA polymerase II activity. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
A cyclin-dependent kinase inhibitor that can impede the transcriptional regulation of genes. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Reduces mRNA synthesis by terminating RNA chain elongation. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits DNA topoisomerase I, leading to DNA damage and potentially affecting gene transcription. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Crosslinks DNA, thereby inhibiting DNA synthesis and subsequent gene transcription. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
Forms DNA adducts, which can disrupt transcription and DNA replication processes. | ||||||